骨髓增生异常综合征(myelodysplastic syndro-me,MDS)传统称为隐袭性白血病、白血病前期(Prel-eukemia)等。其主要表现为贫血,常伴全血细胞减少、感染和出血现象;骨髓增生活跃或明显活跃,三系细胞有明显病态造血的一组疾病。自法、美、英(FAB)协作组提出诊断及分型建议后,该病研究进展较快。现将近几年治疗情况综述报道如下。 Myelodysplastic syndro-me (MDS) is traditionally called latent leukemia, pre-eukemia and so on. Its main manifestations of anemia, often accompanied by pancytopenia, infection and bleeding; bone marrow hyperplasia was active or significantly active, three-line cells were significantly sick hematopoietic group of diseases. Since France, the United States, Britain (FAB) collaborative group put forward the diagnosis and classification recommendations, the disease progresses rapidly. In recent years, the review of treatment are reported below.